Doç. Dr. ÜMİT YAVUZ MALKAN

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Differential proinflammatory responses of colon epithelial cells to SARS-CoV-2 spike protein and <i>Pseudomonas aeruginosa</i> lipopolysaccharide

YILMAZ A., Turk S., MALKAN Ü. Y., HAZNEDAROĞLU İ. C., Ucar G., ÖZGÜVEN Ş. V., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.49, ss.774-783, 2024 (SCI-Expanded)

Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

Yiğit Kaya S., MUTLU Y. G., MALKAN Ü. Y., MEHTAP Ö., Keklik Karadağ F., Korkmaz G., et al.

Leukemia Research , cilt.140, 2024 (SCI-Expanded)

Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study

FIRAT O., KARA E., MALKAN Ü. Y., Demirkan K., İNKAYA A. Ç.

Thrombosis Research , cilt.236, ss.155-160, 2024 (SCI-Expanded)

Pathogens in Pediatric Septic Arthritis: A Multi-Center Study in Turkiye (PEDSART Study)

Iseri Nepesov M., KILIÇ Ö., Sali E., Yesil E., Akar A., Kaman A., et al.

Children , cilt.11, sa.1, 2024 (SCI-Expanded)

Prognostic gene biomarkers for c-Src inhibitor Si162 sensitivity in melanoma cells

TÜRK S., YILMAZ A., MALKAN Ü. Y., UÇAR G., TÜRK C.

Turkish Journal of Biology , cilt.48, sa.1, ss.13-23, 2024 (SCI-Expanded)

The Potential Role of CAL2 and EZH2 Immunohistochemical Stainings as Diagnostic and Prognostic Surrogate Markers in Classical BCR/ABL1-negative Myeloproliferative Neoplasms

ÖZOĞUL E., Ozgeyik M. O., AYHAN E. A., MALKAN Ü. Y., HAZNEDAROĞLU İ. C., ÜNER A.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.33, sa.4, ss.248-257, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

The Relationship of Vitamin D Levels with Hematological Neoplasia

Topcu F. B., Ozdemir S., MALKAN Ü. Y.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.33, sa.4, ss.227-239, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of Ibrutinib

ILTAR U., SALİM O., Atas U., Vural E., Alhan F. N., YÜCEL O. K., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.33, sa.4, ss.191-197, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines.

TÜRK S., Yanpar H., Baesmat A. S., Canli S., ÇINAR O. E., MALKAN Ü. Y., et al.

Heliyon , cilt.9, sa.9, 2023 (SCI-Expanded)

Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.

Malkan Ü. Y., Haznedaroglu I. C.

European review for medical and pharmacological sciences , cilt.27, sa.12, ss.5493-5506, 2023 (SCI-Expanded)

The Prognostic Significance of Prognostic Nutritional Index in Diffuse Large B Cell Lymphoma Patients

Aras M. R., Yilmaz F., Tiglioglu M., Saglam B., Yuzgenc B., Afacan Ozturk H. B., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.1, ss.8-13, 2023 (SCI-Expanded)

Hypophosphatemia related to the use of ibrutinib

KARADENİZ M., ÇINAR O. E., Erdogdu B., MALKAN Ü. Y., GÖKER H., ÖZCEBE O. İ.

Journal of Oncology Pharmacy Practice , 2023 (SCI-Expanded)

Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome

ŞENEL E., TÜRK S., MALKAN Ü. Y., Peker M. Ç., TÜRK C., GÜNER H. R., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.5, ss.1194-1204, 2023 (SCI-Expanded)

Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia After Hematopoietic Stem Cell Transplantation: A Cohort Study in a Tertiary Center Real-World Setting.

Göker H., Çınar O. E., Demiroğlu H., Malkan Ü. Y., Aladağ Karakulak E., Büyükaşık Y.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.40, ss.213-215, 2023 (SCI-Expanded)

The probiotic-induced dysregulation of immune-related genes in colon cells and relation with colorectal cancer

Türk S., Yılmaz A., Safari Baesmat A., Malkan Ü. Y., Ucar G., Türk C.

Cellular and Molecular Biology , cilt.69, sa.4, ss.37-45, 2023 (SCI-Expanded)

The Impact of JAK2 Mutation on Thrombosis in Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

Arslan Kapuci A., Tiglioglu P., Hanci L. T., Saat H., MALKAN Ü. Y.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.2, ss.83-91, 2023 (SCI-Expanded)

A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded)

The Relationship Between GLIM Criteria and Recovery Times in the Leukemia Treatment Process

Yilmaz F., Aras M. R., Afacan Ozturk H. B., MALKAN Ü. Y., Kapuci A. A., Gunes A. K., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.3, ss.121-126, 2023 (SCI-Expanded)

Harbinger of Trouble; Fingerprints in the Pre-Senile Stage of NK Cell’s Dysfunction

TÜRK S., Baesmat A. S., YILMAZ A., MALKAN Ü. Y., TÜRK C., HAZNEDAROĞLU İ. C., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.2, ss.66-74, 2023 (SCI-Expanded)

Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874

ÇINAR O. E., Erdogdu B., KARADENİZ M., ÜNAL S., MALKAN Ü. Y., GÖKER H., et al.

MEDICINA-LITHUANIA , cilt.58, sa.11, 2022 (SCI-Expanded)

NK-cell dysfunction of acute myeloid leukemia in relation to the renin-angiotensin system and neurotransmitter genes

TÜRK S., Baesmat A. S., YILMAZ A., TÜRK C., MALKAN Ü. Y., UÇAR G., et al.

OPEN MEDICINE , cilt.17, sa.1, ss.1495-1506, 2022 (SCI-Expanded)

Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

Çınar O. E., Göker H., Fidan K., Aydın Ö., Pashayev T., Malkan Ü. Y., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.39, sa.3, ss.152-159, 2022 (SCI-Expanded)

Determination of etiology in patients admitted due to isolated leukopenia.

Mart G., Malkan Ü. Y., Buyukasik Y.

Medicine , cilt.101, sa.33, 2022 (SCI-Expanded)

Antineoplastic Effects of Ankaferd Hemostat.

Malkan Ü. Y., Haznedaroglu I. C.

BioMed research international , cilt.2022, ss.2665903, 2022 (SCI-Expanded)

Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

Tiglioglu P., Albayrak M., Yildiz A., Tiglioglu M., Saglam B., Aras M. R., et al.

JOURNAL OF HEMATOPATHOLOGY , cilt.15, ss.83-93, 2022 (SCI-Expanded)

Association of Human Leukocyte Antigen Genotypes with Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-Induced Subacute Thyroiditis

ŞENDUR S. N., ÖZMEN F., Oguz S. H., GÖNÜL İREMLİ B., MALKAN Ü. Y., Gurlek A., et al.

THYROID , cilt.32, sa.6, ss.640-647, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded)

Hematological aspects of the COVID-19 syndrome

MALKAN Ü. Y., Haznedaroglu I. C.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.26, sa.12, ss.4463-4476, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

The Effect of CRAB Findings on the Prognosis of Multiple Myeloma Patients

Kalkisim A. F., Kalkisim H. K., MALKAN Ü. Y.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.191-201, 2022 (SCI-Expanded)

Improving Survival Besides the High Early Mortality Rate in Acute Promyelocytic Leukemia

Malkan Ü. Y., Koca E., BÜYÜKAŞIK Y.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.1-7, 2022 (SCI-Expanded)

Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded)

Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Assessing the genetic impact of Enterococcus faecalis infection on gastric cell line MKN74

TÜRK S., Turk C., Temirci E. S., Malkan Ü. Y., UÇAR G., Ozguven S. V.

ANNALS OF MICROBIOLOGY , cilt.71, sa.1, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case

Afacan Ozturk H. B., Albayrak M., Maral S., Reis Aras M., Yilmaz F., Akyol P., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.8, ss.2027-2029, 2021 (SCI-Expanded)

Current community transmission and future perspectives on the COVID-19 process

TÜRK S., Turk C., Malkan Ü. Y., Temirci E. S., Peker M. C., HAZNEDAROĞLU İ. C.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.3, ss.1001-1011, 2021 (SCI-Expanded)

A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis

MALKAN Ü. Y., Albayrak M., Yildiz A., Maral S., Afacan Ozturk H. B., Comert P.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.1, ss.250-252, 2021 (SCI-Expanded)

The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.

Karataş A., Malkan Ü. Y., Velet M., Demiroğlu H., Büyükaşik Y., Telli Dizman G., et al.

Turkish journal of medical sciences , cilt.51, ss.1647-1652, 2021 (SCI-Expanded)

Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

ALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.1, ss.355-358, 2021 (SCI-Expanded)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.

OPEN MEDICINE , cilt.16, sa.1, ss.192-197, 2021 (SCI-Expanded)

Interferon-Gene Family Alterations Following the SARS-Cov Infection in Association with Iron Metabolism and Lymphoid Biology

Malkan Ü. Y., TÜRK S., Turk C., Temirci E. S., Koker I., HAZNEDAROĞLU İ. C.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.31, sa.2, ss.67-78, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide

Turk S., Turk C., Akbar M., Kucukkaraduman B., Isbilen M., Demirkol C., et al.

PLOS ONE , cilt.15, sa.11, 2020 (SCI-Expanded)

In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus

Turk C., TÜRK S., Temirci E. S., Malkan Ü. Y., HAZNEDAROĞLU İ. C.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.21, sa.2, 2020 (SCI-Expanded)

Richter's transformation in patients with chronic lymphocytic leukemia: a cohort study about risk factors

OKAY M., GÜNEŞ G., Malkan Ü. Y., Heziyev T., GÖKER H., HAZNEDAROĞLU İ. C., et al.

LEUKEMIA & LYMPHOMA , cilt.61, ss.50-52, 2020 (SCI-Expanded)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.4, ss.256-262, 2020 (SCI-Expanded)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia

Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.116-120, 2020 (SCI-Expanded)

Three critical clinicobiological phases of the human SARS-associated coronavirus infections

Turk C., Turk S., Malkan Ü. Y., Haznedaroglu I. C.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.24, sa.16, ss.8606-8620, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded)

Ankaferd Hemostat Affects Etoposide Resistance of the Malignant Melanoma Cells

Ghasemi M., OKAY M., Malkan Ü. Y., TÜRK S., Jabbar J., Hocaoglu H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.1, ss.43-53, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Mantle cell lymphoma: a Turkish Multi-Center Study

OKAY M., MELETLİ Ö., KELKİTLİ E., Malkan Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.

JOURNAL OF BUON , cilt.24, sa.5, ss.2084-2089, 2019 (SCI-Expanded)

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

Ghasemi M., OKAY M., TÜRK S., Naeemaee R., Guver E., Malkan Ü. Y., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.20, sa.2, 2019 (SCI-Expanded)

The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.

GHASEMİ m., OKAY M., TÜRK S., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., et al.

Journal Of The Renin-Angiotensin-Aldosterone System , 2019 (SCI-Expanded)

Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors

Gunes G., GÖKER H., DEMİROĞLU H., Malkan Ü. Y., BÜYÜKAŞIK Y.

BONE MARROW TRANSPLANTATION , cilt.54, sa.4, ss.595-600, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.3, ss.177-182, 2019 (SCI-Expanded)

Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., Malkan Ü. Y., Saglam E. A., DEMİROĞLU H.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.12, sa.7, ss.9288-9294, 2019 (SCI-Expanded)

The factors affecting early death in newly diagnosed APL patients

Ciftciler R., HAZNEDAROĞLU İ. C., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE , cilt.14, sa.1, ss.647-652, 2019 (SCI-Expanded)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded)

Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia

Ciftciler R., AKSU S., Malkan Ü. Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.29, sa.1, ss.14-21, 2019 (SCI-Expanded)

A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded)

Indications and outcomes of splenectomy for hematological disorders

Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE , cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded)

Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded)

Combination of novoseven and feiba in hemophiliac patients with inhibitors

Malkan Ü. Y., AKSU S.

OPEN MEDICINE , cilt.13, sa.1, ss.618-621, 2018 (SCI-Expanded)

Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded)

Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis

Malkan Ü. Y., ÖZCEBE O. İ.

TRANSFUSION AND APHERESIS SCIENCE , cilt.56, sa.6, ss.880-882, 2017 (SCI-Expanded)

The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia

Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.

LEUKEMIA & LYMPHOMA , cilt.58, ss.96, 2017 (SCI-Expanded)

Lipotoxicity-Related Hematological Disorders in Obesity

HAZNEDAROĞLU İ. C., MALKAN Ü. Y.

OBESITY AND LIPOTOXICITY , cilt.960, ss.469-487, 2017 (SCI-Expanded)

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.103-104, 2017 (SCI-Expanded)

Ankaferd hemostat induces DNA damage, apoptosis and cytotoxic activity by generating reactive oxygen species in melanoma and normal cell lines

KOÇYİĞİT A., GÜLER E. M., HAZNEDAROĞLU İ. C., Malkan Ü. Y.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.10, sa.2, ss.2116-2126, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

A myelofibrosis case that develops mycobacterial infection after ruxolitinib treatment

Malkan Ü. Y., HAZNEDAROĞLU İ. C.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.10, sa.4, ss.7304-7307, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis

Gunes H. N., Cokal B. G., Guler S. K., Yoldas T. K., Malkan Ü. Y., Demircan C. S., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.44, sa.6, ss.1454-1461, 2016 (SCI-Expanded)

Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level

HURİ E., Dogantekin E., HAYRAN M., MALKAN Ü. Y., Ergun M., FIRAT A., et al.

SPRINGERPLUS , cilt.5, 2016 (SCI-Expanded)

Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies

Haznedaroglu I. C., Malkan Ü. Y.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.19, ss.4089-4111, 2016 (SCI-Expanded)

Reply: Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib

Malkan U. Y., GÜNEŞ G., ETGÜL S., Aslan T., Aydin S., HAZNEDAROĞLU İ. C.

ANNALS OF PHARMACOTHERAPY , cilt.50, sa.4, ss.336, 2016 (SCI-Expanded)

Chimeric antigen receptor T cell treatment in hematologic malignancies

GÖKER H., Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.35-40, 2016 (SCI-Expanded)

The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded)

A CML case with resistant pleural effusion with tyrosine kinase inhibitor treatment

Malkan Ü. Y., HAZNEDAROĞLU İ. C.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.7, ss.14884-14887, 2016 (SCI-Expanded)

A Bing-Neel syndrome case

Malkan Ü. Y., HAZNEDAROĞLU İ. C.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.11, ss.22660-22663, 2016 (SCI-Expanded)

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids

Koluman A., Akar N., Malkan U. Y., HAZNEDAROĞLU İ. C.

BIOMED RESEARCH INTERNATIONAL , cilt.2016, 2016 (SCI-Expanded)

The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.153-158, 2016 (SCI-Expanded)

Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

GHASEMİ m., ALPSOY S., TÜRK TÜRK S., MALKAN Ü. Y., ATAKAN Ş., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.286-292, 2016 (SCI-Expanded)

Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded)

The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers

Malkan Ü. Y., Gunes G., Corakci A.

SPRINGERPLUS , cilt.4, 2015 (SCI-Expanded)

Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., Aslan T., Balaban S., HAZNEDAROĞLU İ. C.

ANNALS OF PHARMACOTHERAPY , cilt.49, sa.6, ss.740-742, 2015 (SCI-Expanded)

Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice

Eylem E., Yahya B., Ozlen B., Umit M., Gursel G., Ayse I., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.9, ss.16334-16339, 2015 (SCI-Expanded)

A T-cell prolymphocytic leukemia case with central nervous system involvement

Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H., YEŞİLIRMAK A., ÜNER A.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.8, ss.14207-14209, 2015 (SCI-Expanded)

Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML

Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.25, sa.4, ss.215-221, 2015 (SCI-Expanded)

Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded)

The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded)

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.

ACTA HAEMATOLOGICA , cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded)

Common variable immune deficiency associated Hodgkin's lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report

Malkan Ü. Y., GÜNEŞ G., Aslan T., ETGÜL S., Aydin S., BÜYÜKAŞIK Y.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.8, ss.14203-14206, 2015 (SCI-Expanded)

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded)

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report

MALKAN Ü. Y., Gunes G., Eliacik E., ISIK A., AKSU S., ATİLLA B., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.286-288, 2014 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?

REİS ARAS M., Afacan Öztürk H. B., yılmaz f., Güneş A. K., Malkan U. Y., ALBAYRAK M.

Hitit medical journal (Online) , cilt.5, sa.3, ss.170-174, 2023 (Hakemli Dergi)

IMMUNOGENOMIC APPROACH TO THE CLINICAL MANAGEMENT OF COVID-19 SYNDROME

TÜRK S., HAZNEDAROĞLU İ. C., TÜRK C., malkan Ü. Y.

Eskisehir Medical Journal, Eskisehir City Hospital , 2023 (Hakemli Dergi)

Pharmacobiology of topical Ankaferd hemostat in neoplastic disorders

Malkan U. Y., Haznedaroglu I. C.

The European Research Journal , cilt.9, sa.5, ss.1271-1276, 2023 (Hakemli Dergi)

Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control study

GÖKER H., ÇINAR O. E., ISMAYILOV R., Özdemir E., MALKAN Ü. Y., ALADAĞ E., et al.

Acta Medica , cilt.54, sa.2, ss.97-102, 2023 (Hakemli Dergi)

A rare case of DIC in a patient with Wilson's disease: D-penicillamine

PARLAR Y. E., BALABAN H. Y., MALKAN Ü. Y., DENİZ E., UYSAL F. R.

HEPATOLOGY FORUM , cilt.3, sa.2, ss.61-63, 2022 (ESCI)

A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA APPLIED WITH AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION

Karadeniz M., Ucdal M. T., Goker H., Malkan Ü. Y.

Hematology, Transfusion and Cell Therapy , cilt.43, ss.1-3, 2021 (ESCI)

Analysis of Demographic and Clinical Characteristics of Primary Myelofibrosis and Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis Patients

Akyol P., Yıldız A., Albayrak M., Öztürk H. B. A., Maral S., Aras M. R., et al.

Gulhane Medical Journal , cilt.63, sa.2, ss.117-122, 2021 (Scopus)

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)

Ciftciler R., Ciftciler A. E., Malkan Ü. Y., HAZNEDAROĞLU İ. C.

SAGE OPEN MEDICINE , cilt.8, 2020 (ESCI)

A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

MALKAN Ü. Y., Albayrak M., Ozturk H. B., Aras M. R., Saglam B., Dogan K.

CASE REPORTS IN ONCOLOGY , cilt.13, sa.3, ss.1368-1372, 2020 (ESCI)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines

TÜRK TÜRK S., Malkan Ü. Y., Ghasemi M., Hocaoglu H., Mutlu D., Gunes G., et al.

SAGE OPEN MEDICINE , cilt.5, 2017 (ESCI)

Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , cilt.9, ss.61-64, 2016 (ESCI)

Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse

Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H.

CASE REPORTS IN MEDICINE , 2015 (ESCI)

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease

GÜNEŞ G., DEMİROĞLU H., GÖKER H., Malkan Ü. Y., ELİAÇIK E., Yayar O., et al.

CASE REPORTS IN HEMATOLOGY , 2015 (ESCI)

Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., HAZNEDAROĞLU İ. C.

CASE REPORTS IN HEMATOLOGY , 2015 (ESCI)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Retrospective Analysis of Turkish AML Registry Database, on Behalf of AML Working Group of Turkish Society of Hematology

Karakus V., Sevindik O. G., Karatas A., Yenihayat E. M., Polat M. G., Celik S., et al.

cilt.140, ss.8946-8947

LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.

44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.191-192

LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73

Lenalidomide provide better progression free survival than thalidomide and bortezomib in the first relapse of multiple myeloma patients after autologous transplantation

Malkan Ü. Y., Buyukasik Y., Demiroglu H., Ciftciler R., Gunes G., Okay M., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73

Descriptive analysis of myeloproliferative diseases and its complications

OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73

RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.

6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018

RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.

5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Kıbrıs (Kktc), 20 - 22 Eylül 2018

Erken Evre Kronik Lenfositer Löseminin Nadir Görünümleri ve Bir Mide Kanseri Vakası Birlikteliği: 2 vaka sunumu.

AYDIN M. S., ÜNER A., OKAY M., MALKAN Ü. Y., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 05 Kasım 2017, cilt.1, ss.66 Sürdürülebilir Kalkınma

RARE PRESENTATIONS OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA AND A COINCIDENCE WITH GASTRIC CANCER: 2 CASES

AYDIN M. S., ÜNER A., malkan Ü. Y., OKAY M., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

LEUKEMIA RESEARCH, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16 Sürdürülebilir Kalkınma

SYNCHRONOUS GRANULOCYTIC SARCOMA AND MYCOBACTERIUM TUBERCULOSIS DIAGNOSED IN AN AXILLARY LYMPH NODE

Malkan Ü. Y., Khurami F. A., Arslankoz S., Arikok A., Can E. S., Albayrak M., et al.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

ELTROMBOPAG INDUCED HEPATOTOXICITY: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

AN ANAPLASTIC THYROID CARCINOMA CASE PRESENTING WITH LEUCOERYTHROBLASTIC BLOOD PICTURE

Okay M., Malkan Ü. Y., Can E. S., Gunes G., Demiroglu H.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

METHOTREXATE-RITUXIMAB TREATMENT IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

DIMETHYL SULFOXIDE-INDUCED TONIC-CLONIC SEIZURE DURING INFUSION OF AUTOLOGOUS STEM CELL

Maral S., Albayrak M., Sahin O., Yildiz A., Pala C., Malkan Ü. Y., et al.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

AN UNMUTATED HYPEREOSINOPHILIC SYNDROME CASE THAT IS SUCCESFULLY TREATED WITH IMATINIB MESYLATE

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

IMPORTANCE OF SCREENING ACCESSORY SPLEEN IN REFRACTORY IMMUNE THROMBOCYTOPENIA

Sahin O., Albayrak M., Yildiz A., Maral S., Ozturk C. P., Ozturk H. A., et al.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

COEXISTENCE OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA AND VITILIGO: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

SJOGREN SYNDROME RELATED IMMUNE THROMBOCYTOPENIC PURPURA: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

A CASE OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL IMMUNOPHENOTYPE

Okay M., Malkan Ü. Y., Can E. S., Gunes G., Demiroglu H.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

BLEOMYCIN-INDUCED PULMONARY FIBROSIS: EXPERIENCE OF TWO CASES IN A SINGLE CENTRE

Maral S., Albayrak M., Yildiz A., Sahin O., Ozturk C., Malkan Ü. Y., et al.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

THE CORRELATION BETWEEN THE JAK2 ALLELE BURDEN AND HEMATOLOGIC/ CLINICAL PARAMETERS OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA PATIENTS

Can E. S., Malkan Ü. Y., Okay M., Albayrak M., Gunes G.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

THE EFFECT OF DISEASE STATUS BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION ON OVERALL SURVIVAL IN MULTIPLE MYELOMA

Gunes G., Malkan Ü. Y., Can E. S., Yayar O., Okay M., Goker H.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

A CASE REPORT: IMATINIB-RELATED PSORIASIFORM DERMATITIS

Sahin O., Albayrak M., Yildiz A., Maral S., Gunes G., Ozturk C. P., et al.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

COMPARISON OF BORTEZOMIB AND LENALIDOMIDE BASED REGIMENS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS

Malkan Ü. Y., Gunes G., Yayar O., Can E. S., Okay M., Goker H.

8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61

Amyloidosis Induced Abnormal coagulopathy associated with multible coagulation Factor Deficiencies.

malkan Ü. Y., DEMİROĞLU H., AKSU S., HAZNEDAROĞLU İ. C., SAYINALP N.

XXVI. Congress of the international society on Thrombosis and Haemostasis, Berlin, Almanya, 08 Temmuz 2017 - 13 Ocak 2018, cilt.1, ss.402

The Impact of Chemo/Immune Therapy-‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia

OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.

iwcll2017, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017

Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi

ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

2. Hematolojik Onkoloji Kongresi, Kıbrıs (Kktc), 16 - 19 Şubat 2017

Experience with Pegylated Interferon alpha-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Bahcecioglu A. B., Etgul S., Aslan T., Aydin M. S., Malkan Ü. Y., Okay M., et al.

58th Annual Meeting and Exposition of the American-Society-of-Hematology, California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128

GASTRIC INVOLVEMENT AS CLINICAL PRESENTATION OF BURKITT LYMPHOMA: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

COEXISTENCE OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AND AUTOIMMUNE HEMOLYTIC ANEMIA: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Ciftciler R., Aksu S.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

A HYPERHEMOLYTIC SYNDROME CASE

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

A MYELOFIBROSIS CASE THAT DEVELOPS MYCOBACTERIUM INFECTION AFTER RUXOLITINIB TREATMENT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

ERDHEIM-CHESTER DISEASE: A CASE REPORT

Ciftciler R., Okay M., Malkan Ü. Y., Gunes G., Buyukasik Y.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

AN OSLER WEBER RENDU SYNDROME CASE THAT WAS SUCCESSFULLY TREATED WITH BEVACIZUMAB

Malkan Ü. Y., Gunes G., Okay M., Aksu S., Buyukasik Y.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

ATYPICAL CLINICAL PRESENTATION OF A HODGKIN LYMPHOMA CASE

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Saglam A., Buyukasik Y.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

ANCA POSITIVE VASCULITIS THAT WAS TRIGGERED AFTER BENDAMUSTINE-RITUXIMAB TREATMENT: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I., Sayinalp N.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

A CATASTROPHIC SERONEGATIVE ANTIPHOSPHOLIPID SYNDROME CASE

Malkan Ü. Y., Gunes G., Okay M., Ciftciler R., Buyukasik Y.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

DERMATOSIS CAUSED BY ENOXAPARIN TREATMENT: A CASE REPORT

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

THE COEXISTENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CASTLEMAN SYNDROME: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I., Ozcebe O.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

AN INV(16) POSITIVE ACUTE MYELOMONOCYTIC LEUKEMIA CASE WITH POOR PROGNOSIS

Malkan Ü. Y., Gunes G., Okay M., Ciftciler R., Aksu S.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

AN IGE MYELOMA CASE

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

THE COEXISTENCE OF ANGIOIMMUNOBLASTIC T CELL LYMPHOMA, CHRONIC MYELOMONOCYTIC LEUKEMIA AND EBV: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Demiroglu H.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

IBRUTINIB TREATMENT IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Aksu S., Sayinalp N.

7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49

Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia

TÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.373-374

Determination of chemoterapoetic drugsensitivity subgroups of acute leukemia

Türk S., Ghasemi M., malkan Ü. Y., ERİKÇİ A., GÖKER H., HAZNEDAROĞLU İ. C., et al.

The FEBS Journal, 3 - 08 Eylül 2016

USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY

Cekdemir D., Ozdemirkiran F., Guvenc S., Eser A., Ozkocaman V., Sahin H. H., et al.

24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141